World's largest vaccine manufacturer signs agreement with St. Jude
Parents around the world — and their children — can breathe a sigh of relief: St. Jude Children's Research Hospital has signed a licensing agreement to complete development and commercialization of an RSV vaccine.
The agreement between the hospital and the Serum Institute of India gives the latter the exclusive right t o complete development of a St. Jude vaccine against respiratory syncytial virus (RSV) for use in South America, Africa and much of Asia.
“RSV remains a serious threat to infants…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Elle Perry Source Type: news
More News: African Health | Biotechnology | Child Development | Children | Health Management | Hospitals | India Health | Respiratory Medicine | Vaccines